Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 1,267 | 294,123 |
| Gross Profit | N/A | N/A | 0 | 1,267 | 294,123 |
| Operating Expenses | 116,593 | 117,715 | 132,572 | 115,062 | 123,640 |
| Operating Income | -116,593 | -117,715 | -132,572 | -113,795 | 170,483 |
| Other Income | 17,567 | 15,913 | 13,129 | 14,442 | 12,900 |
| Pre-tax Income | -99,026 | -101,802 | -119,443 | -99,353 | 183,383 |
| Net Income Continuous | -99,026 | -101,802 | -119,473 | -99,353 | 183,383 |
| Net Income | $-99,026 | $-101,802 | $-119,473 | $-99,353 | $183,383 |
| EPS Basic Total Ops | -0.59 | -0.68 | -0.88 | -0.72 | 1.34 |
| EPS Basic Continuous Ops | -0.59 | -0.68 | -0.87 | -0.72 | 1.34 |
| EPS Diluted Total Ops | -0.59 | -0.68 | -0.84 | -0.72 | 1.30 |
| EPS Diluted Continuous Ops | -0.59 | -0.68 | -0.83 | -0.72 | 1.30 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.68 | -0.86 | N/A | N/A |
| EBITDA(a) | $-124,709 | $-126,069 | $-142,638 | $-123,901 | $161,235 |